{ "company_number": "09434517", "name": "Pharmacell Medication Systems Limited", "url": "/company/09434517", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2015-02-11", "dissolved_on": null, "sic_codes": [ { "code": "27900", "description": "Manufacture of other electrical equipment", "section": "C", "section_name": "Manufacturing", "url": "/sic/27900" } ], "registered_address": { "id": 1470186, "url": "/address/1470186", "line1": "MARKET HOUSE 10", "line2": "MARKET WALK", "post_town": "SAFFRON WALDEN", "county": "ESSEX", "country": "", "postcode": "CB10 1JZ" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/09434517", "previous_names": [], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2026-12-31", "last_made_up": "2025-03-31", "category": "TOTAL EXEMPTION FULL", "filings": [ { "url": "/company/09434517/accounts/2025-03-31", "pdf_url": "/company/09434517/accounts/2025-03-31.pdf", "made_up_date": "2025-03-31", "period_start": "2025-03-31", "period_end": "2025-03-31", "entity_name": "Pharmacell Medication Systems Limited", "dormant": false, "average_employees": "0.00", "tangible_fixed_assets": "17555.00", "debtors": "228577.00", "cash_bank_in_hand": "17095.00", "current_assets": "253150.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "108520.00", "total_assets_less_current_liabilities": "126075.00", "net_assets_liabilities": "123609.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "4.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2025.zip" }, { "url": "/company/09434517/accounts/2024-03-31", "pdf_url": "/company/09434517/accounts/2024-03-31.pdf", "made_up_date": "2024-03-31", "period_start": "2024-03-31", "period_end": "2024-03-31", "entity_name": "Pharmacell Medication Systems Limited", "dormant": false, "average_employees": "4.00", "tangible_fixed_assets": "77812.00", "debtors": "196446.00", "cash_bank_in_hand": "24708.00", "current_assets": "226237.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "54126.00", "total_assets_less_current_liabilities": "131938.00", "net_assets_liabilities": "112974.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "4.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2024.zip" }, { "url": "/company/09434517/accounts/2023-03-31", "pdf_url": "/company/09434517/accounts/2023-03-31.pdf", "made_up_date": "2023-03-31", "period_start": "2023-03-31", "period_end": "2023-03-31", "entity_name": "Pharmacell Medication Systems Limited", "dormant": false, "average_employees": "4.00", "tangible_fixed_assets": "124370.00", "debtors": "167683.00", "cash_bank_in_hand": "79702.00", "current_assets": "251591.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-6583.00", "total_assets_less_current_liabilities": "117787.00", "net_assets_liabilities": "110484.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "4.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2023.zip" }, { "url": "/company/09434517/accounts/2022-03-31", "pdf_url": "/company/09434517/accounts/2022-03-31.pdf", "made_up_date": "2022-03-31", "period_start": "2022-03-31", "period_end": "2022-03-31", "entity_name": "Pharmacell Medication Systems Limited", "dormant": false, "average_employees": "4.00", "tangible_fixed_assets": "183977.00", "debtors": "97838.00", "cash_bank_in_hand": "19235.00", "current_assets": "122245.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-137660.00", "total_assets_less_current_liabilities": "46317.00", "net_assets_liabilities": "38105.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "4.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2023.zip" }, { "url": "/company/09434517/accounts/2021-03-31", "pdf_url": "/company/09434517/accounts/2021-03-31.pdf", "made_up_date": "2021-03-31", "period_start": "2021-03-31", "period_end": "2021-03-31", "entity_name": "Pharmacell Medication Systems Limited", "dormant": false, "average_employees": "4.00", "tangible_fixed_assets": "243586.00", "debtors": "91583.00", "cash_bank_in_hand": "5201.00", "current_assets": "101172.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-80493.00", "total_assets_less_current_liabilities": "163093.00", "net_assets_liabilities": "26499.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "4.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2021.zip" }, { "url": "/company/09434517/accounts/2020-03-31", "pdf_url": "/company/09434517/accounts/2020-03-31.pdf", "made_up_date": "2020-03-31", "period_start": "2020-03-31", "period_end": "2020-03-31", "entity_name": "Pharmacell Medication Systems Limited", "dormant": false, "average_employees": "4.00", "tangible_fixed_assets": "303197.00", "debtors": "51662.00", "cash_bank_in_hand": "34969.00", "current_assets": "97159.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-118975.00", "total_assets_less_current_liabilities": "184222.00", "net_assets_liabilities": "41787.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "4.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2021.zip" }, { "url": "/company/09434517/accounts/2019-03-31", "pdf_url": "/company/09434517/accounts/2019-03-31.pdf", "made_up_date": "2019-03-31", "period_start": "2019-03-31", "period_end": "2019-03-31", "entity_name": "Pharmacell Medication Systems Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "362810.00", "debtors": "127679.00", "cash_bank_in_hand": "23682.00", "current_assets": "156465.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-152905.00", "total_assets_less_current_liabilities": "209905.00", "net_assets_liabilities": "58447.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "4.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2019.zip" }, { "url": "/company/09434517/accounts/2018-03-31", "pdf_url": "/company/09434517/accounts/2018-03-31.pdf", "made_up_date": "2018-03-31", "period_start": "2018-03-31", "period_end": "2018-03-31", "entity_name": "Pharmacell Medication Systems Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "99274.00", "debtors": "101215.00", "cash_bank_in_hand": "10611.00", "current_assets": "115280.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-165208.00", "total_assets_less_current_liabilities": "257253.00", "net_assets_liabilities": "16591.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "4.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2018.zip" }, { "url": "/company/09434517/accounts/2017-03-31", "pdf_url": "/company/09434517/accounts/2017-03-31.pdf", "made_up_date": "2017-03-31", "period_start": "2017-03-31", "period_end": "2017-03-31", "entity_name": "Pharmacell Medication Systems Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "113167.00", "debtors": "40047.00", "cash_bank_in_hand": "39912.00", "current_assets": "83117.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-178333.00", "total_assets_less_current_liabilities": "303557.00", "net_assets_liabilities": "-30132.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "4.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2017.zip" }, { "url": "/company/09434517/accounts/2016-03-31", "pdf_url": "/company/09434517/accounts/2016-03-31.pdf", "made_up_date": "2016-03-31", "period_start": "2016-03-31", "period_end": "2016-03-31", "entity_name": "Pharmacell Medication Systems Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "541427.00", "debtors": "65877.00", "cash_bank_in_hand": "78747.00", "current_assets": "147953.00", "creditors_due_within_one_year": "249242.00", "creditors_due_after_one_year": "420779.00", "net_current_assets_liabilities": "-101289.00", "total_assets_less_current_liabilities": "440138.00", "net_assets_liabilities": "10738.00", "called_up_share_capital": "4.00", "profit_loss_account_reserve": "10734.00", "shareholder_funds": "10738.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2016.zip" } ], "pdf_only_filings": [], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/09434517/filing-history" }, "confirmation_statement": { "next_due": "2027-04-28", "last_made_up": "2026-04-14" }, "officers": [], "psc": [ { "name": "Mrs Caroline Tremayne Milne", "kind": "individual-person-with-significant-control", "person_url": "/person/780948", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent", "voting-rights-25-to-50-percent" ], "notified_on": "2016-04-06", "ceased_on": "2017-10-24", "nationality": "British", "country_of_residence": "United Kingdom", "source": "snapshot" }, { "name": "Mr Adrian Christopher John Milne", "kind": "individual-person-with-significant-control", "person_url": "/person/92026", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent", "voting-rights-25-to-50-percent" ], "notified_on": "2016-04-06", "ceased_on": "2017-10-24", "nationality": "British", "country_of_residence": "United Kingdom", "source": "snapshot" }, { "name": "Pivotell Limited", "kind": "corporate-entity-person-with-significant-control", "person_url": null, "controlling_company_url": "/company/04437866", "natures_of_control": [ "ownership-of-shares-25-to-50-percent", "voting-rights-25-to-50-percent" ], "notified_on": "2023-12-01", "ceased_on": null, "nationality": "", "country_of_residence": "", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-08-01", "retrieved_at": "2026-08-14T22:50:00.959197+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }